Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET
The Prostate · 2025-06 · 85 (8) · 777-783
DOI: 10.1002/pros.24884 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, online erschienen am 27.02.2025. Verfasst von Baris Esen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Koc University Hospital, Istanbul, Turkiye. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Lymph Node Excision, Lymph Nodes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
PSMA PET/CT has previously shown superior performance in nodal staging of prostate cancer (PCa) and may be used to reduce the number of unnecessary PLND procedures. This study aims to assess the performance of PSMA PET/CT in nodal staging of intermediate‐risk prostate cancer and to evaluate the effect of PLND on oncological outcomes of intermediate‐risk prostate cancer patients with a negative PSMA PET/CT.
Methods
A total of 308 patients with intermediate‐risk PCa who underwent PSMA PET/CT for nodal staging between January 2014 and July 2024 were included in the study. Patients who underwent PLND had higher PSA and higher rates of PIRADS‐5 and biopsy grade‐group 3 disease. A 1:1 propensity score matching was performed to eliminate patient characteristics differences between groups and 140 patients were included in the final analysis. PSA persistence rates ( ≥ 0.1 ng/dL) and biochemical recurrence (BCR; ≥ 0.2 ng/dL) rates after RP were recorded. Kaplan‐Meier curves were constructed to evaluate oncological outcomes. Log‐rank test was utilized to compare oncological outcomes in patients with and without PLND.
Results
The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PSMA PET/CT on nodal staging were 53.3%, 95%, 47.1%, and 96.1%, respectively. The NPV of PSMA PET/CT in patients with biopsy GG3 disease (96.3%) was similar to those with biopsy GG2 disease (95.6%). The median follow‐up after propensity score matching was 20.7 months. The 24‐month BCR‐free survival rates were 83.7% and 86.9% in the PLND‐RP group and RP‐only groups, respectively ( p = 0.078).
Conclusions
NPV of PSMA PET/CT in determining LNI was remarkable in patients with intermediate‐risk PCa and PLND was found to have no impact on oncological outcomes. Therefore PLND may be omitted to decrease surgery‐related complications in patients with intermediate‐risk PCa a negative PSMA PET/CT for nodal staging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Koc University Hospital, Istanbul, Turkiye.
- Department of Nuclear Medicine, Koc University Hospital, Istanbul, Turkiye.
- Department of Pathology, Koc University Hospital, Istanbul, Turkiye.
- Department of Urology, Tokat Gaziosmanpasa University Hospital, Tokat, Turkiye.
- RMK AIMES, Rahmi M. Koc Academy of Interventional Medicine, Education, and Simulation, Istanbul, Turkiye.
- Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Baris Esen, Derya Tilki
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Esen, B., Seymen, H., Armutlu, A., Koseoglu, E., Aykanat, I. C., Zoroğlu, H., Canda, A. E., Kordan, Y., Balbay, M. D., Baydar, D. E., Demirkol, M. O., Tilki, D., & Esen, T. (2025). Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET. The Prostate, 85(8), 777-783. https://doi.org/10.1002/pros.24884
Vancouver
Esen B, Seymen H, Armutlu A, Koseoglu E, Aykanat IC, Zoroğlu H, et al. Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET. The Prostate. 2025;85(8):777-783. doi:10.1002/pros.24884
BibTeX
@article{Esen2025,
author = {Esen, Baris and Seymen, Hulya and Armutlu, Ayşe and Koseoglu, Ersin and Aykanat, Ibrahim Can and Zoroğlu, Hatice and Canda, Abdullah Erdem and Kordan, Yakup and Balbay, Mevlana Derya and Baydar, Dilek Ertoy and Demirkol, Mehmet Onur and Tilki, Derya and Esen, Tarık},
title = {Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET},
journal = {The Prostate},
year = {2025},
volume = {85},
number = {8},
pages = {777--783},
doi = {10.1002/pros.24884}
}
EUVIMED